PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Biology III, Faculty of Biology, University of Freiburg, Freiburg, Germany.\', \'Research Centres Bioss, Centre for Biological signal studies, CIBSS, Centre for Integrative Biological Signalling Studies, University of Freiburg, Freiburg, Germany.\', \'Department of Cancer and Immunology, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.\', \'Institute of Clinical and Molecular Virology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.\', \'Division of Molecular Immunology, Internal Medicine III, Nikolaus-Fiebiger-Center of Molecular Medicine, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.\', \'Department of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.\', \'Center for Chronic Immunodeficiency, Medical Center, University of Freiburg, Freiburg, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2021.730766
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34630410
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
?:title
  • A Barcoded Flow Cytometric Assay to Explore the Antibody Responses Against SARS-CoV-2 Spike and Its Variants.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all